Compliance Now
OCTOBER 23, 2023
By Megan Diehl, Manager of Compliance Consulting, MZQ Consulting The Patient-Centered Outcomes Research Institute (PCORI) fee established by the Affordable Care Act helps fund research to evaluate and compare health outcomes, clinical effectiveness, risks, and benefits of medical treatment and services.
Compliance Now
NOVEMBER 21, 2022
By: Megan Diehl , Manager, Compliance Consulting, MZQ Consulting. The fee is currently in place through 2029. In Notice 2022-59 , the IRS announced that the PCORI fee for plan years ending between October 1, 2022 and September 30, 2023 is $3.00.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Compliance Now
NOVEMBER 21, 2022
By: Megan Diehl , Manager, Compliance Consulting, MZQ Consulting. The fee is currently in place through 2029. In Notice 2022-59 , the IRS announced that the PCORI fee for plan years ending between October 1, 2022 and September 30, 2023 is $3.00.
Total HIPAA
JUNE 6, 2022
This mode enables backward compatibility and will be supported through at least 2029. The post Microsoft Announces End of Support for Internet Explorer appeared first on Total HIPAA Compliance. Microsoft says customers should move to Microsoft Edge with IE mode.
Healthcare IT Today
DECEMBER 2, 2022
between now and 2029. In addition, healthcare organizations can feel confident that their solution is meeting all regulatory and compliance requirements. . The following is a guest article by d’Artagnan Osborne, General Manager of Payment Solutions at Kareo , a Tebra company. Flexible and customizable payment plan options.
Innovaare Compliance
APRIL 7, 2024
The base beneficiary premium (BBP) will be capped at 6% from prior year from 2024 to 2029 [3]. Part D plans’ share of costs will increase from 15% to 60% for both brands and generics in the catastrophic phase, and drug manufacturers will be required to provide a 20% price discount on brand-name drugs [2].
Innovaare Compliance
APRIL 7, 2024
The base beneficiary premium (BBP) will be capped at 6% from prior year from 2024 to 2029 [3]. Part D plans’ share of costs will increase from 15% to 60% for both brands and generics in the catastrophic phase, and drug manufacturers will be required to provide a 20% price discount on brand-name drugs [2].
Expert insights. Personalized for you.
100 
Let's personalize your content